Ajanta Pharma USA Inc: Aripiprazole Tablets Usp

Ajanta Pharma USA Inc is recalling Aripiprazole Tablets USP 30 mg (NDC 27241-056-03) distributed nationwide because some bottles were mislabeled and contain Voriconazole 50 mg instead. Aripiprazole is used to treat mental health conditions, while Voriconazole is an antifungal medication, so patients taking the recalled product would be receiving the wrong medication. The affected product was manufactured in India and distributed across all U.S. states and Washington, D.C.

Recalling firm
Ajanta Pharma USA Inc
Product
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.
Reason
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Category
drug recall
Country
United States
Agency
U.S. Food and Drug Administration
Recall date
2026-05-27
Status
Ongoing
Areas affected
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
Distribution
U.S. Nationwide

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/0af24804-7eeb-4157-8fd3-872c6d37de76